Lipoprotein(a) is a potential coronary risk factor

Japanese Circulation Journal

Volumn 64, Issue 1, 2000, Pages 51-56

  Fujino, Akihisa ^a,c   Watanabe, Tatsuya ^a   Kunii, Hiroyuki ^a   Yamaguchi, Nozomi ^a   Yoshinari, Kazuyuki ^a   Watanabe, Yasuyuki ^a   Mutou, Mitsuru ^a   Ishikawa, Syunichi ^a   Ogyuu, Atsuhiro ^a   Ashikawa, Kouichi ^a   Maruyama, Yukio ^b  

^a Yonezawa City Hospital   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c Yonezawa City Hospital   (Japan)

Author keywords

Coronary cineangiogram; Coronary risk factors; Lp(a); Multiple regression test

Indexed keywords

CHOLESTEROL; LIPOPROTEIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CINEANGIOCARDIOGRAPHY; CORONARY BLOOD VESSEL; CORONARY RISK; FAMILY HISTORY; FEMALE; GENDER; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 0346299241     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.51     Document Type: Article

References (18)

1. Berg K: A new serum type sysem in man: the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-382
2. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 300: 132-137
3. Dahlen GH: Lipoprotein(a) in relation to atherosclerotic diseases. New York: Alan R Liss Inc, 1988: 27-36
4. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H: Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990; 301: 1248-1251
5. Sonoda M, Sakamoto K, Miyauchi T, Sanada J, Nakamura K, Arima T, et al: Risk factors in normolipidemic male patients with coronary artery disease in Japanese. Jpn Circ J 1992; 56: 829-836
6. Honda Y, Oshima S, Ogawa H, Sakamoto T, Miyao Y, Sakata S, et al: Plasma lipoprotein(a) levels and fibrinolytic activity in acute myocardial infarction. Jpn Circ J 1994; 58: 869-876
7. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, et al: Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990; 322: 1494-1499
8. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, et al: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298
9. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U: Detection and quantification of Lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989; 9: 579-592
10. Fujita S, Sano T, Katayama Y: Measurement of serum Lp(a) by COBAS MIRA using a latex immunoturbidimetric assay kit. J Clin Lab Anal 1994; 8: 385-390
11. Friedeward WT: Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
12. Kannel WB, Castelli WP, Gordon T, et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 1971; 74: 1-12
13. Schwartzman R, Cox I, Poloniecki J, Crook R, Seymour C, Kaski J: Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol 1998; 31: 1260-1266
14. Cantin B, Gagnon F, Moorjani M, Despres J, Lamarche B, Lupien P, et al: Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec cardiovascular study. J Am Coll Cardiol 1998; 31: 519-525
15. Pepin JM, O'Neil JA, Hoff HF: Quantification of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res 1991; 32: 317-327
16. Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM: Atherogenesis in transgenic mice with human apolipoproteinB and lipoprotein(a). J Clin Invest 1995; 96: 1639-1646
17. Gurakar A, Hoeg JM, Kostner G, Papadopoulos NM, Brewer HB Jr: Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis 1985; 57: 293-301
18. Fujino A, Sano R, Saito T, Yamaguchi N, Sato H, Midorikawa J, et al: Reduction of serum Lp(a) in patients with ischemic heart disease through long term administration of Niceritrol. J Jpn Atheroscler Soc 1995; 22: 715-720